Healthcare
Syneos Health is one of the major global CROs, combining clinical development services with commercial, consulting, and medical affairs capabilities. Its model is built around supporting sponsors from development through commercialization, making it relevant across the full product lifecycle.
Read More
Swedish Orphan Biovitrum, commonly known as Sobi, is one of Europe’s most important rare disease and orphan drug companies. The company focuses on rare hematology, immunology, and specialty care, with a portfolio designed for specialist-managed diseases.
Read More
Supernus Pharmaceuticals is an established healthcare institution whose principal relevance to this ranking lies in central nervous system specialty medicines. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in specialty Pharma Companies.
Read More
Stoke Therapeutics is an established healthcare institution whose principal relevance to this ranking lies in RNA-based medicines for severe genetic diseases. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in rare Disease & Orphan Drug Developers.
Read More
Soleno Therapeutics is a Neurocrine Biosciences company focused on developing and commercializing treatments for rare diseases, including Prader-Willi syndrome. Neurocrine completed its acquisition of Soleno on 18 May 2026. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in rare Disease & Orphan Drug Developers.
Read More
Sobi is a Swedish specialty pharmaceutical company focused on rare diseases, hematology, immunology, and specialty care. The company’s portfolio and commercial model are closely aligned with orphan and specialist-managed diseases. Highest 2026 tier: Tier II Specialty Pharma Companies 1 ranking category Overview
Read More
SK pharmteco is a global CDMO backed by SK Group, providing services across small molecule APIs, advanced intermediates, cell and gene therapy, viral vector manufacturing, and related pharmaceutical production. Its platform combines U.S., European, and Asian manufacturing assets.
Read More
SK bioscience is an established healthcare institution whose principal relevance to this ranking lies in vaccine development, manufacturing and global partnerships. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in vaccine & Immunotherapy Developers.
Read More
Sinovac Biotech is an established healthcare institution whose principal relevance to this ranking lies in commercial vaccines across viral and bacterial diseases. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in vaccine & Immunotherapy Developers.
Read More
Simbec-Orion is an established healthcare institution whose principal relevance to this ranking lies in early and full-service clinical development for biotech sponsors. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in contract Research Organizations.
Read More
Siegfried is a Swiss CDMO with strong capabilities in drug substance and drug product manufacturing, including active pharmaceutical ingredients, intermediates, oral solid dosage, sterile filling, and related development services. The company has built a strong reputation in pharmaceutical outsourcing across both chemical and finished-dose manufacturing.
Read More
Servier is an established healthcare institution whose principal relevance to this ranking lies in international oncology and specialty pharmaceutical development. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in global Pharmaceutical Companies.
Read More
Serum Institute of India is one of the most important vaccine manufacturers in the world by volume. Its institutional role is especially important in low- and middle-income countries, where large-scale affordable vaccine supply is essential to immunization programs.
Read More
Sarepta Therapeutics is one of the most important rare disease and neuromuscular gene therapy developers. The company is strongly associated with Duchenne muscular dystrophy, where it has developed RNA-based exon-skipping therapies and gene therapy approaches for severe neuromuscular disease.
Read More
Sanofi is one of the world’s leading vaccine companies and a major participant in immunology. Its vaccine business, historically associated with Sanofi Pasteur, spans influenza, pediatric vaccines, meningococcal disease, travel vaccines, and respiratory disease prevention.
Read More
Sana Biotechnology is an established healthcare institution whose principal relevance to this ranking lies in engineered cells and in-vivo cell-modification platforms. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in cell & Gene Therapy Developers.
Read More
Samsung Biologics is one of the most important biologics CDMO providers globally and a defining player in large-scale mammalian cell culture manufacturing. The company has built a highly standardized, large-capacity manufacturing platform in South Korea, serving major pharmaceutical and biotechnology clients across biologics development and commercial supply.
Read More
Rocket Pharmaceuticals is a specialist gene therapy company focused on rare diseases, including hematologic, immunologic, and cardiovascular genetic disorders. The company uses both lentiviral and AAV-based approaches, giving it modality diversity within genetic medicine.
Read More
Rhythm Pharmaceuticals is an established healthcare institution whose principal relevance to this ranking lies in rare genetic obesity therapies. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in rare Disease & Orphan Drug Developers.
Read More
Revolution Medicines is an established healthcare institution whose principal relevance to this ranking lies in biotechnology firms. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in biotechnology Firms.
Read MorePagination
- First page
- Previous page
- …
- 18
- 19
- 20
- …
- Next page
- Last page